In a groundbreaking development in the field of immunology, researchers have discovered a fiery new response to Siglec receptors in the human body. For the first time, scientists have found that the binding of Siglec receptors to their ligands triggers the production of a type of oxidase enzyme known as NADPH oxidase, which then helps to activate white blood cells. This activation is part of the body’s immune response to potential pathogens, and could provide a new target for developing treatments for a variety of diseases.

Read Full Article Here

source: Phys.org